Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2750 results found
2025 ∙ Wang, W. Sawleshwarkar, S. Piraveenan, M.
Computational approaches of modelling human papillomavirus transmission and prevention strategies: a systematic review
All age groups Human papillomavirus (HPV) Modeling
Rating:
Not applicable
2025 ∙ Salleh, N. S. Abdullah, K. L. Chow, H. Y.
Cultural barriers and facilitators of the parents for human papillomavirus (HPV) vaccination uptake by their daughters: A systematic review
Parents/caregivers Human papillomavirus (HPV) Acceptance
Rating:
Not applicable
2025 ∙ Blukacz, A. Obach, A. Vasquez, P. Campana, C. Huerta, C. Bernal, Y. Cabieses, B.
Determinants of COVID-19 and non-COVID-19 vaccine confidence in low- and middle-income countries: A systematic review of qualitative evidence and thematic synthesis
All age groups Low and Middle Income Countries COVID-19 Acceptance
Rating:
Not applicable
2025 ∙ Bachmann, M. Gultekin, N. Stanga, Z. Fehr, J. S. Ulgur, I. I. Schlagenhauf, P.
Disparities in response to mRNA SARS-CoV-2 vaccines according to sex and age: A systematic review
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Moore, M. Anderson, L. Schiffer, J. T. Matrajt, L. Dimitrov, D.
Durability of COVID-19 vaccine and infection induced immunity: A systematic review and meta-regression analysis
All age groups COVID-19 Efficacy/effectiveness Administration
Rating:
Critically low
2025 ∙ Jiao, X. Zhu, J. Ding, Y. Xiao, M. Zhai, Z.
Effect of herpes zoster vaccine on patients after hematopoietic stem cell transplantation: a systematic review and meta-analysis
All age groups Herpes zoster Efficacy/effectiveness Safety
Rating:
Critically low
2025 ∙ Zhou, G. Dael, N. Verweij, S. Balafas, S. Mubarik, S. Rengerink, K. O. Pasmooij, A. M. G. van Baarle, D. Mol, P. G. M. de Bock, G. H. Hak, E.
Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies published up to 22 January 2024
Europe Adolescents Adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Pelzer, P. T. Stuck, L. Martinez, L. Richards, A. S. Acuna-Villaorduna, C. Aronson, N. E. Bonnet, M. Carvalho, A. C. Chan, P. C. Huang, L. M. Fang, C. T. Churchyard, G. Corral-Londono, H. D. Datta, M. Espinal, M. A. Fielding, K. Fiore-Gartland, A. J. Garcia-Basteiro, A. Hanekom, W. Hatherill, M. Hill, P. C. Huerga, H. Jones-Lopez, E. C. Kritski, A. Mandalakas, A. M. Mangtani, P. Martins Netto, E. Mayanja, H. Mazahir, R. Murray, M. Rangaka, M. Scriba, T. Singh, J. Singh, S. Stein, C. M. Vekemans, J. Verhagen, L. M. Villalba, J. A. Wajja, A. Watson, B. White, R. G. Cobelens, F. G. J.
Effectiveness of the primary Bacillus Calmette-Guerin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant data
All age groups Tuberculosis Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Wu, H. Li, L. Fu, K. Shen, Y. Lu, Y. Liao, Z. Liu, Y. Zha, W. Wu, L. Zhang, Y.
Effects of different-valent vaccines against human papillomavirus (HPV) to prevent persistent HPV16/18 infections and CIN2+ in women: a systematic review and network meta-analysis
All age groups Human papillomavirus (HPV) Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Jotautis, V. Sarantaki, A.
Evaluating the Efficacy and Safety of Hepatitis E Vaccination in Reproductive-Age Women: A Systematic Review and Meta-Analysis
Adolescents Adults Hepatitis E Efficacy/effectiveness Safety
Rating:
Critically low
Loading...